Opinions varied among practitioners regarding psychological support when treating with psychedelics, although an emotive ...

The diabetes medication Ozempic has emerged as an unexpected player in the weight loss arena, sparking intense ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

Harmony Biosciences Holdings said the Food and Drug Administration has turned away its application seeking expanded approval of its Wakix narcolepsy drug for the treatment of excessive daytime ...

Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...

The FDA has accepted a priority review of a new biannual HIV prevention injection, with a decision expected by June 19, 2025.

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less effective drug.

Rundown trailers streaked with graffiti that sit along a windy gravel road just outside Ontario in eastern Oregon are part of ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

Supernus Pharmaceuticals may have had a potential path forward for its depression drug candidate cut off after the asset ...

The Vatican says Pope Francis slept peacefully and ate breakfast after developing pneumonia in both his lungs.

APL was once a highly fatal disease, with up to 30% of patients dying early from complications. Traditional treatments often ...